IL1B and Alzheimer disease: In turn, IL-1β production was increased in the group treated with LPS plus feline fibroblast-derived exosomes (774.00 ± 22.54 pg/mL) but was significantly blocked after the administration of LPS plus feline AD-MSC-derived exosomes (536.44 ± 121.92 pg/mL).